Belgian and German researchers have presented a new imaging tool that can track immune cells invading the...
Up To Date
Latest News
Despite declining numbers of IPOs, financing rounds and licensing deals, the European biotech sector...
After AstraZeneca removed its NSCLC drug osimertinib from the German market following a benefit assessment of...
A new analysis comparing the amount of funding invested into stem cell research clearly demonstrates declining...
Investors are once again flocking to back biotechs in Europe. Belgian Life Sciences fund Fund+ has raised...
Share
